Lale Erdem‐Eraslan

<i>MGMT</i> -STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951

Martin J. van den Bent, Lale Erdem‐Eraslan, Ahmed Idbaïh et al. · Clinical Cancer Research · 2013 · 122 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

Lale Erdem‐Eraslan, Lonneke A.M. Gravendeel, Johan de Rooi et al. · Journal of Clinical Oncology · 2012 · 110 citations · Full text

Medicine, Cancer Biology, Oncology +17

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate et al. · Cancer Research · 2016 · 99 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Ya Gao, Bas Weenink, Martin J. van den Bent et al. · European Journal of Cancer · 2018 · 39 citations

Medicine, Cancer Biology, Oncology +15

Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation

Lale Erdem‐Eraslan, Ya Gao, Nanne K. Kloosterhof et al. · European Journal of Cancer · 2015 · 30 citations · Full text

Medicine, Genetics, Molecular Biology +14